MarketInOut Stock Screener Log In | Sign Up
 

Alpha Tau Medical Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 09/21/2026 11:53
Alpha Tau Medical Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,409.37 mln
Float64.27 mln
Earnings Date11/24/2026

Piotroski F-Score

3 / 9
Below average

1-Year Forecast

17.80
Attractive

Relative Strength

82 / 100
Strongly outperforming

Debt / Equity

0.34
Low leverage

ROE

-130
Deeply negative

ROA

-82.02
Deeply negative

Business Description

Alpha Tau Medical is an Israel-based medical company developing a new type of radiation treatment for solid tumors called Alpha DaRT. The therapy works by placing small radioactive seeds directly into a tumor, where they release high-energy alpha particles to destroy cancer cells. The company is currently testing this approach in clinical trials across a wide range of cancer types, including skin, prostate, pancreatic, lung, liver, and breast cancers.

Key Fundamentals

EPS-1.04
ROE-130
ROIC-177
ROA-82.02
Interest Cover-1.22
EBITDA, mln-92.04
EV / EBITDA-13.83
EV / EBIT-13.83

Quote Details

Last 15.47
Change 0.23 (1.51%)
Open 15.48
Volume 157,334
Turnover 2,433,957
Average Volume 627,433

Financial Ratios

Leverage Ratio3.05
Current Ratio11.09
Price / Book30.80
Price / Tangible Book30.60
Debt / Equity0.34

Financial Strength

Piotroski F-Score 3 / 9
1-Year Target Price17.80
Short Ratio5.11
Short % of Float4.81

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.43% 87 / 100   
1 Month 7.73% 87 / 100   
2 Months 57.06% 96 / 100   
6 Months 119% 97 / 100   
1 Year 306% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us